Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?
A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding...
| Autores principales: | Stark, HL, Wang, HC, Kuburic, J, Alzhrani, A, Hester, J, Issa, F |
|---|---|
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
Frontiers Media
2021
|
Ejemplares similares
-
Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?
por: Helen L. Stark, et al.
Publicado: (2021-03-01) -
An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
por: Alzhrani, AI
Publicado: (2021) -
Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
por: Honeyman, C, et al.
Publicado: (2021) -
Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
por: Honeyman, C, et al.
Publicado: (2020) -
Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
por: Maja-Theresa Dieterlen, et al.
Publicado: (2021-08-01)